Venlafaxine Hydrochloride
Product Images NDC 50090-5725

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905725)

Label for Venlafaxine hydrochloride extended-release capsules, 150 mg strength, by A-S Medication Solutions. The label states storage instructions to keep at 68 to 77 degrees Fahrenheit and indicates a package size of 30 capsules. The label also includes a lot number and NDC 50090-5725-0.*

FDA Label Image

Fig-1 (Venlafaxine Fig 1)

A pharmacokinetic (PK) fold change chart showing the effects of various interacting drugs on venlafaxine and its metabolite ODV, with PK parameters Cmax and AUC. The chart plots fold change values with 90% confidence intervals and includes dosing recommendations, such as avoiding ethanol, no dose adjustment for diazepam and lithium, and use caution notes for cimetidine, ketoconazole, metoprolol, and others.*

FDA Label Image

Fig-2 (Venlafaxine Fig 2)

A chart illustrating pharmacokinetic fold changes and 90% confidence intervals for various analytes when interacting with different drugs. The x-axis shows change relative to a reference value, while the y-axis lists interacting drugs and corresponding analytes, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. Recommendations regarding dose adjustment and clinical significance accompany the data on the right side.*

FDA Label Image

Fig-3 (Venlafaxine Fig 3)

A chart depicting fold changes and 90% confidence intervals for venlafaxine and its metabolite ODV pharmacokinetics (Cmax and AUC) across various special populations including hepatic and renal impairment, CYP2D6 polymorphism, age over 60 years, and gender. Recommendations on dose adjustments are listed on the right, correlating with the observed pharmacokinetic changes.*

FDA Label Image

Str (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing its molecular arrangement, including a methoxy-substituted aromatic ring, a cyclohexanol group, and associated hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.